No Routine Investigation Required Before Prescribing Contraception
For a healthy 41-year-old woman with no complaints requesting contraception, no examination or laboratory test from the options provided (FSH, TSH, transvaginal ultrasound, or endometrial biopsy) is required before prescribing most contraceptive methods. 1, 2
Evidence-Based Requirements by Contraceptive Method
Most Hormonal Methods (Pills, Patch, Ring, Implant, Injectable)
- Blood pressure measurement is the only mandatory examination before initiating combined hormonal contraceptives 1, 2
- Blood pressure can even be self-reported if healthcare access is limited 2
- No pelvic examination, laboratory tests, or imaging studies are needed 1, 2
- The package insert for oral contraceptive pills explicitly states that gynecologic examination is unnecessary 1
Progestin-Only Methods
- No examinations or tests whatsoever are required before initiating progestin-only pills, implants, or injections 1, 2
IUD or Diaphragm (The Only Exceptions)
- Bimanual examination and cervical inspection are mandatory only for IUD insertion or diaphragm fitting 1, 2
- These methods require anatomic assessment because variation could affect insertion or proper sizing 1
Why the Listed Tests Are NOT Indicated
FSH Testing (Option A)
- FSH measurement is not required for contraceptive initiation 1
- FSH is relevant only when evaluating amenorrhea or determining menopausal status, not for prescribing contraception to a woman with regular cycles 1
TSH Testing (Option B)
- TSH screening is not required before contraception 1, 2
- While thyroid dysfunction can affect menstrual cycles, it does not contraindicate hormonal contraception 1
Transvaginal Ultrasound (Option C)
- Pelvic imaging is not required for contraceptive initiation 1, 2
- Ultrasound is indicated only when evaluating specific gynecologic complaints like abnormal bleeding or pelvic pain 1
Endometrial Biopsy (Option D)
- Endometrial sampling is never required before contraception 1, 2
- This invasive procedure is reserved for evaluating abnormal uterine bleeding, not for asymptomatic contraceptive candidates 1
Additional Tests That Are Also Unnecessary
The following are explicitly classified as Class C (not contributing substantially to safe contraceptive use) 1, 2:
- Pelvic examination (bimanual or speculum) 1, 2
- Cervical cytology (Pap smear) 1, 2
- Clinical breast examination 1, 2
- Glucose, lipid, or liver enzyme panels 1, 2
- Hemoglobin or thrombogenic mutation testing 1
- HIV or STI screening (unless clinically indicated for other reasons) 1, 2
Clinical Rationale and Common Pitfalls
Why This Approach Is Evidence-Based
- No findings on physical examination would contraindicate oral contraceptives in an asymptomatic woman 1
- The low prevalence of conditions like diabetes, hyperlipidemia, or liver disease among reproductive-age women makes screening asymptomatic patients of minimal value 3
- Requiring unnecessary examinations creates logistical, emotional, and economic barriers that reduce contraceptive access and paradoxically increase unintended pregnancy rates 1, 4
Critical Pitfall to Avoid
- Do not delay or deny contraception while waiting for "routine" screening tests 1, 2
- A 2021 nationwide survey found that 16-23% of providers incorrectly required unnecessary pelvic examinations before non-IUD hormonal methods, and 14-33% required unnecessary breast exams, Pap smears, or STI screening 5
- These practices are not evidence-based and represent barriers to care 5, 4
What IS Recommended
For Combined Hormonal Contraceptives
- Blood pressure measurement only (can be obtained in non-clinical settings) 1, 2
- Medical history review to identify contraindications per U.S. Medical Eligibility Criteria 1
Optional Baseline Measurement
- Weight and BMI may be recorded at baseline for future monitoring and counseling about perceived weight changes, but are not required for medical eligibility determination 1, 2
- All contraceptive methods can be used by women with obesity 1, 2